Azerbaijan vs Sao Tome and Principe: HIV-positive TB patients on ART (antiretroviral therapy)
Azerbaijan
100.0%
in 2024
Sao Tome and Principe
100.0%
in 2024
Azerbaijan rank
1st
Sao Tome and Principe rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Azerbaijan
- Sao Tome and Principe
How they compare
Azerbaijan currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
Across all 14 years both countries report, Sao Tome and Principe has been ahead every year.
Azerbaijan ranks 1st and Sao Tome and Principe ranks 1st of 144 countries.
Sao Tome and Principe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.8% | 100.0% | 26.2% | Sao Tome and Principe |
| 2020s | 98.2% | 100.0% | 1.8% | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Azerbaijan or Sao Tome and Principe?
- Azerbaijan, at 100.0% against 100.0% in Sao Tome and Principe as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Azerbaijan and Sao Tome and Principe?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Sao Tome and Principe?
- 14 years are reported by both, from 2011 to 2024.
- How do Azerbaijan and Sao Tome and Principe rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Azerbaijan ranks 1st and Sao Tome and Principe ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.